Document is current
Any future updates will be listed below
-
Authors
Zhong, Songxiao https://orcid.org/0000-0001-8426-3905
Oh, Tae Rin https://orcid.org/0009-0000-4549-8322
Li, Xindi
Zhang, Jinming
Choi, Suk Won
Gao, Chuyun https://orcid.org/0000-0002-6116-0011
Peng, Xu https://orcid.org/0000-0001-9068-102X
Dong, Juan
He, Chuan https://orcid.org/0000-0003-4319-7424
Zhang, Xiuren https://orcid.org/0000-0001-8982-2999
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM151976)
NSF | BIO | Division of Molecular and Cellular Biosciences (2139857)
Welch Foundation (A-2177-20230405)
Howard Hughes Medical Institute
- License Information
-
More Information
Article History
Received: 20 October 2025
Accepted: 9 April 2026
First Online: 8 May 2026
Competing interests
: C.H. is a scientific founder, member of the scientific advisory board and equity holder of Aferna Bio, Ellis Bio and AllyRNA, and a scientific cofounder and equity holder of Accent Therapeutics. The other authors declare no competing interests.
